Halma appoints Sharmila Nebhrajani OBE as independent non-executive Director

British American Tobacco
[shareaholic app="share_buttons" id_name="post_below_content"]

Halma plc (LON:HLMA), the FTSE 100 global group of life-saving technology companies, has announced the appointment of Sharmila Nebhrajani OBE as an independent non-executive Director, effective 1 December 2021. Sharmila will also be a member of Halma’s Audit, Remuneration and Nomination Committees.

Sharmila brings a wealth of experience gained across a variety of roles – spanning both the public and private/NGO sectors – with a particularly strong background in sustainability and health. She is currently a non-executive director at ITV plc and Severn Trent plc, and Chair of the National Institute for Health and Care Excellence (NICE).

Sharmila was Chief Executive of Wilton Park (part of the Foreign and Commonwealth Office), responsible for convening international policy dialogue with governments, NGOs, policy makers and academics on topics such as global health and climate risk. Previously, she worked for the Medical Research Council, Association of Medical Research Charities and NHS Sussex. In her earlier career, she held senior positions within the BBC, Cable & Wireless plc and PwC.    

Dame Louise Makin, Chair, commented:              
“I am delighted that Sharmila has agreed to join the Halma Board. Her diverse experience, particularly in the health and medical sector, will undoubtedly bring a fresh perspective and valuable insights to the Board.”

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    Halma plc (LON:HLMA) has released its full year results for the year ending 31 March 2024. Explore the financial details and dividend information here.
    Halma plc (LON: HLMA) releases its trading update for the financial year, showing strong growth and strategic investments. Full year results expected on 13 June 2024.
    Halma plc has appointed Giles Kerr as an independent non-executive Director, bringing valuable insights from his extensive experience in life sciences and technology sectors. Roy Twite will step down as a Director on 7 June 2024.

      Search

      Search